RhodioRex® powerful adaptogen & reduce stress

RhodioRex® is an Rhodiola rosea extract trademark of Shanghai Aidu Biotechnology Co., Ltd, a manufacturer, supplier and marketer of herbal extracts applied in dietary supplements, sports nutrition and food industries.

Aidu supplies authentic RhodioRex® with the high quality that was confirmed by an international third part - Eurofins.

Serial Number 88948751
Registration Number 6398027
Status 700 - Registered
Status Date 2021-06-22
Filing Date 2020-06-04
Registration Number 6398027
Registration Date 2021-06-22
Mark Drawing 4000 - Standard character mark Typeset
Published for Opposition Date 2020-10-13

Current Trademark Owners

Party Name Shanghai Aidu Biotechnology Co. Ltd.
Party Type 30 - Original Registrant
Legal Entity Type 99 - Other (limited company (td.)).

Meet RhodioRex®

RhodioRex®s the world’s first standardrised Rhodiola Rosea Root Extract to be made commercially available on the market.

Known for more than thousand years, Rhodiola rosea is widely used in the traditional Chinese medicine as an anti-stress in order to stimulate the immune system and an adaptogenic herb. The main components Rosavin and Salidroside are considered responsible for the excellent properties of Rhodiola Rosea.

RhodioRex®is 100% identity guaranteed and supported by centuries of traditional use for mental and physical stress.

• Adaptogenic
• Improves recovery
• Helps protect muscle cells
• Improves endurance
• Special grade: BSCG® Certified Drug Free

• Helps reduce fatigue
• Improves memory
• Improves anxiety and depression
• Offers antioxidant and anti inflammatory properties

RhodioRex® offers authentic Rhodiola rosea species, use the world’s best source in Altai Mountains.

RhodioRex® -Rhodiola Rosea Extract

BOTANICAL ORIGIN Rhodiola rosea (roots)
BIOACTIVES Rosavins ≥3% & Salidroside ≥1%
Extract ratio 4:1~8:1
Rosavins ≥5% & Salidroside ≥2%
Extract ratio 10:1~15:1
LATIN  NAME Rhodiola Rosea L.
CULTIVATED OR WILD Cultivated/Wild-crafted in Altai
APPEARANCE Brown fine powder
SHELF LIFE 3 years
PACKAGING 1kg, 5kg, 25kg
RhodioRex® is adapted to Capsules, tablets but also sachets or powders.

Our facility is designed and operated according to GMP requirements, packed in the 100000 class clean area, which ensures the edible safety, the stability of the product quality.
100% natural extracted by the process of low temperature extraction and low temperature drying. Ensure the effective ingredient.
Comply with USP and EU Standardization.
Low microorganism, low heavy metal, low pesticide residues, low PAHs, Low PAs, Perchloric acid < 0.5 ppm, meet with European standard, equivalent to organic products.
Tested by independent lab-Eurofins, SGS etc.

Where to buy RhodioRex® Rhodiola Rosea Extract?
RhodioRex® Rhodiola Rosea extract is standardized to 3% Rosavins and 1% Salidroside, 5% Rosavins and 2% Salidroside.
RhodioRex® is now available from Shanghai Aidu Biotechnology Co., Ltd in China and USA.

More on RhodioRex®
We are here to help.
Have any questions? Need clarification? Need free sample?
Our representatives are here to help!

These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Scientific References
Pooja, et al. Anti-inflammatory Activity of Rhodiola rosea – “A Second-generation Adaptogen”. Phytother. Res. 23, 1099–102 (2009).


♦ Edwards, D., Heufelder, A., & Zimmermann, A. (2012). Therapeutic Effects and Safety of Rhodiola rosea Extract WS® 1375 in Subjects with Life‐stress Symptoms–Results of an Open‐label Study. Phytotherapy Research, 26(8), 1220-1225.

♦ Hung, S. K., Perry, R., & Ernst, E. (2011). The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine, 18(4), 235-244.

♦ Olsson, E. M., von Schéele, B., & Panossian, A. G. (2009). A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta medica, 75(02), 105-112.

♦ Getova, D. P., & Mihaylova, A. S. (2013). Effects of Rhodiola rosea extract on passive avoidance tests in rats. Central European Journal of Medicine, 8(2), 176-181.

♦ Darbinyan, V., Kteyan, A., Panossian, A., Gabrielian, E., Wikman, G., & Wagner, H. (2000). Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine, 7(5), 365-371.

♦ Spasov, A. A., Wikman, G. K., Mandrikov, V. B., Mironova, I. A., & Neumoin, V. V. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, 7(2), 85-89.

♦ Spasov, A. A., Mandrikov, V. B., & Mironova, I. A. (1999). The effect of the preparation rodakson on the psychophysiological and physical adaptation of students to an academic load. Eksperimental'naia i klinicheskaia farmakologiia, 63(1), 76-78.

♦ De Bock, K., Eijnde, B. O., Ramaekers, M., & Hespel, P. (2004). Acute Rhodiola rosea intake can improve endurance exercise performance. International journal of sport nutrition and exercise metabolism, 14(3), 298-307.

♦ Shevtsov, V. A., Zholus, B. I., Shervarly, V. I., Vol'skij, V. B., Korovin, Y. P., Khristich, M. P., ... & Wikman, G. (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine, 10(2), 95-105.

♦ Aslanyan, G., Amroyan, E., Gabrielyan, E., Nylander, M., Wikman, G., & Panossian, A. (2010). Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. Phytomedicine, 17(7), 494-499.

♦ Sheng, Q. S., Wang, Z. J., Zhang, J., & Zhang, Y. G. (2013). Salidroside promotes peripheral nerve regeneration following crush injury to the sciatic nerve in rats. Neuroreport, 24(5), 217-223.

♦ Darbinyan, V., Aslanyan, G., Amroyan, E., Gabrielyan, E., Malmström, C., & Panossian, A. (2007). Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nordic journal of psychiatry, 61(5), 343-348.

♦ Bystritsky, A., Kerwin, L., & Feusner, J. D. (2008). A pilot study of Rhodiola rosea (Rhodax®) for generalized anxiety disorder (GAD). The Journal of Alternative and Complementary Medicine, 14(2), 175-180.

♦ McElwee, J. J., Schuster, E., Blanc, E., Piper, M. D., Thomas, J. H., Patel, D. S., ... & Gems, D. (2007). Evolutionary conservation of regulated longevity assurance mechanisms. Genome biology, 8(7), R132.

♦ Partridge, L., & Gems, D. (2002). Mechanisms of aging: public or private?. Nature Reviews Genetics, 3(3), 165-175.

♦ Panossian, A., & Wikman, G. (2009). Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Current clinical pharmacology, 4(3), 198-219.

♦ Kim, S. H., Hyun, S. H., & Choung, S. Y. (2006). Antioxidative effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver of diabetic mice. Biofactors, 26(3), 209-219.